Darling Ingredients (DAR)
(Delayed Data from NYSE)
$36.11 USD
-0.18 (-0.50%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $36.10 -0.01 (-0.03%) 5:12 PM ET
5-Strong Sell of 5 5
B Value D Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$36.11 USD
-0.18 (-0.50%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $36.10 -0.01 (-0.03%) 5:12 PM ET
5-Strong Sell of 5 5
B Value D Growth B Momentum C VGM
Zacks News
Darling Ingredients (DAR) to Report Q3 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Darling (DAR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Medifast (MED) Looks Just Ahead of Q3 Earnings
by Zacks Equity Research
Medifast's (MED) third-quarter results are likely to reflect gains from consumers' increased inclination toward health products amid the pandemic. However, high costs are a concern.
Why the Earnings Surprise Streak Could Continue for Darling (DAR)
by Zacks Equity Research
Darling (DAR) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
5 Low Leverage Stocks to Buy for a Healthy Portfolio
by Aparajita Dutta
Although debt financing is more popular compared to equity financing, it remains a feasible option as long as the companies succeed in generating higher rate of return than the interest rate
Philip Morris (PM) Tops Q3 Earnings Estimates, Raises Guidance
by Zacks Equity Research
Philip Morris' (PM) third-quarter 2020 results reflect solid pricing variance, though soft cigarette volumes hurt revenues and earnings. Management raises earnings per share view for 2020.
Is Darling Ingredients (DAR) a Good Stock for Value Investors?
by Zacks Equity Research
Let's see if Darling Ingredients Inc. (DAR) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Darling Ingredients (DAR) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Darling (DAR) delivered earnings and revenue surprises of 5.41% and 2.73%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Darling Ingredients (DAR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Darling Ingredients (DAR) Q1 Earnings Top Estimates
by Zacks Equity Research
Darling (DAR) delivered earnings and revenue surprises of 21.43% and -0.33%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Darling Ingredients (DAR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Darling (DAR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks.com featured highlights include: Darling Ingredients, Verso, Rocky Brands, Hilltop and Westlake Chemical Partners
by Zacks Equity Research
Zacks.com featured highlights include: Darling Ingredients, Verso, Rocky Brands, Hilltop and Westlake Chemical Partners
Invest in These 7 Price-to-Sales Stocks for Optimum Returns
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Is Darling Ingredients (DAR) Stock Undervalued Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Here's Why General Mills (GIS) Stock Appears Appetizing Now
by Zacks Equity Research
General Mills' (GIS) raised fiscal 2020 guidance is a key positive. The company expects increased orders from retail customers across North America and Europe amid coronavirus.
Zacks.com featured highlights include: MGM Growth Properties, Darling Ingredients, Rocky Brands, Hilltop and Piper Jaffray Companies
by Zacks Equity Research
Zacks.com featured highlights include: MGM Growth Properties, Darling Ingredients, Rocky Brands, Hilltop and Piper Jaffray Companies
7 Low Price-to-Sales Stocks to Consider Amid Coronavirus Woes
by Zacks Equity Research
A stock's price-to-sales ratio reflects how much investors are paying for each dollar of revenues generated by a company.
Should Value Investors Buy Darling Ingredients (DAR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
What Makes Darling (DAR) a New Buy Stock
by Zacks Equity Research
Darling (DAR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Should Value Investors Buy Darling Ingredients (DAR) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Hershey Temporarily Shuts 2 Locations Due to Coronavirus
by Zacks Equity Research
Hershey (HSY) temporarily shuts down its Chocolate World locations in Hershey, Pa., and Times Square, New York City.
TreeHouse Foods Down More Than 20% in 3 Months on Drab Sales
by Zacks Equity Research
TreeHouse Foods (THS) has been bearing the brunt of softness in the Baked Goods and Meal Solutions segments. Also, gross margin has been under pressure.
United Natural (UNFI) Q2 Earnings Top Estimates, View Lowered
by Zacks Equity Research
United Natural's (UNFI) second-quarter fiscal 2020 results are hurt by charges related to three customer bankruptcies. This compels management to lower earnings and adjusted EBITDA guidance.
Colgate's (CL) 2.3% Dividend Hike Boosts Shareholder Value
by Zacks Equity Research
Colgate (CL) hikes quarterly cash dividend to 44 cents per share from 43 cents. Its efforts regarding product innovation and in-store implementation bode well.
Smucker's (SJM) Focus on Buyouts & Savings Plan Bodes Well
by Zacks Equity Research
Smucker (SJM) is likely to benefit from buyouts, alliances, innovation and digital advancements. Also, it is on track with the saving plan.
Campbell Soup (CPB) Stands Tall Amid Coronavirus Jitters
by Zacks Equity Research
Campbell Soup (CPB) has been benefiting from focus on refining portfolio and stringent cost-saving measures.